Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Fractal rev. psicol ; 33(1): 12-20, jan.-abr. 2021.
Artículo en Portugués | LILACS, Index Psicología - Revistas | ID: biblio-1154262

RESUMEN

Este estudo tem como objetivo identificar e discutir artigos que se basearam nas contribuições da perspectiva histórico-cultural elaborada por Vygotsky para compreender e explicar a moralidade. Partindo de uma análise das ideias do próprio autor sobre o tema e sobre o contexto histórico no qual elas se inserem, realizou-se uma revisão de artigos que utilizam as ideias de Vygotsky para se dedicar ao estudo da moral. O levantamento realizado em bases de dados científicas permitiu identificar 22 artigos relativos ao tema. O material foi analisado a partir dos seguintes eixos temáticos: perspectivas teóricas adotadas nos estudos; procedimentos metodológicos utilizados; e temas e conceitos discutidos nos estudos, com foco na articulação da teoria histórico-cultural de Vygotsky com o desenvolvimento moral. Apesar da relevância da teoria vygotskiana para a compreensão do desenvolvimento moral, esta perspectiva mostrou-se ainda pouco desenvolvida quando comparada às perspectivas piagetiana e kohlberguianas, mais frequentemente utilizadas em estudos sobre a psicologia do desenvolvimento moral.(AU)


This study aims to identify and discuss articles that were based on contributions from the historical-cultural perspective developed by Vygotsky to understand and explain morality. Starting from an analysis of the author's own ideas on the topic and the historical context in which they are inserted, we conducted a review of articles that used Vygotsky's ideas to to discuss moral issues. The review carried out on scientific databases allowed the identification of 22 articles related to the topic. The material was analyzed from the following thematic axes: theoretical perspectives adopted in the studies; methodological procedures used; and themes and concepts discussed in the studies, focusing on the articulation of Vygotsky's historical-cultural theory with moral development. Despite the relevance of the Vygotskyan theory for understanding of moral development, this perspective of study is shown to be poorly developed when comparing the Piagetian and Kohlberguian perspectives, most frequently used in studies on the psychology of moral development.(AU)


Asunto(s)
Psicología , Moral
2.
J Nephrol ; 26(4): 652-9, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22878980

RESUMEN

BACKGROUND: Accumulating experimental and clinical evidence reveals beneficial effects of n-3 polyunsaturated fatty acids (PUFAs) in kidney disease by modulating inflammation and fibrosis mechanisms that lead to renal failure. METHODS: EPA, DHA (n-3 PUFAs) and AA (n-6 PUFA) effects, compared to those of AngII, on renal fibrotic processes at the extracellular matrix (ECM) level were verified in human mesangial cells in vitro, by means of RT-PCR, mitogenic assay and Western-blot analysis. RESULTS: Unlike AngII, EPA and DHA enhanced the expression of MMP2 and DN, a TGFbeta inhibitor, while decreasing mitogenic factors such as PDGF and bFGF, and cell proliferation. Moreover, n-3 PUFAs elicited Bax expression in AngII-treated cells and downregulated COX-2--an enzyme involved in the inflammatory cascade. The mechanism of action could implicate PPARgamma activation, as this transcription factor was shown to translocate to the nucleus upon n-3 PUFA treatment. CONCLUSIONS: These results complement our previous reports demonstrating that EPA and DHA prevent ECM accumulation and inflammation that typify the fibrotic process, providing new insights into the cellular and molecular mechanisms underlying their beneficial effects. We confirm that n-3 PUFAs could effectively counteract kidney fibrosis development providing a rationale for their use in clinical settings.


Asunto(s)
Ácidos Grasos Omega-3/uso terapéutico , Riñón/patología , Células Cultivadas , Fibrosis/prevención & control , Humanos
3.
Public Health Nutr ; 14(11): 1907-18, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21729477

RESUMEN

OBJECTIVE: The influence of moderate alcohol consumption on renal function is not clear in elderly people. The aim of the present study was to investigate the relationship between alcohol consumption and renal function, expressed as serum creatinine levels and glomerular filtration rates (GFR), in an elderly population. DESIGN: Perspective cohort study. SETTING: Population-based study on an elderly Italian population. SUBJECTS: A sample of 3404 Italian people (1619 women and 1785 men), aged 65-84 years, from the Italian Longitudinal Study on Aging (ILSA). RESULTS: Prevalence and cumulative risk of impaired renal function (defined as GFR ≤ 60 ml/min) were estimated by sex and alcohol consumption groups. Logistic regression analysis adjusting for confounders (age, education, smoking, BMI and medications) and intermediate factors (blood cholesterol and fibrinogen, systolic hypertension and diabetes) showed that alcohol consumption level was not significantly related to the prevalence of mild renal impairment in elderly women. In men, both prevalence and incidence results seemed to suggest an inverse linear relationship between moderate alcohol consumption and the risk of mild renal impairment. A U-shaped association was shown for women at the incidence phase, suggesting a higher risk of developing renal impairment for women who drink more than 24 g alcohol/d. CONCLUSIONS: Our results suggest that, in accordance with the recommendations on alcohol consumption in the elderly, moderate quantities of alcohol are not injurious to renal function in elderly men.


Asunto(s)
Consumo de Bebidas Alcohólicas/epidemiología , Bebidas Alcohólicas , Insuficiencia Renal/epidemiología , Insuficiencia Renal/fisiopatología , Anciano , Anciano de 80 o más Años , Envejecimiento/efectos de los fármacos , Colesterol/sangre , Creatinina/sangre , Femenino , Fibrinógeno/análisis , Estudios de Seguimiento , Tasa de Filtración Glomerular , Humanos , Hipertensión/sangre , Hipertensión/patología , Incidencia , Entrevistas como Asunto , Italia/epidemiología , Modelos Logísticos , Estudios Longitudinales , Masculino , Prevalencia , Insuficiencia Renal/etiología , Factores de Riesgo , Fumar , Encuestas y Cuestionarios
4.
G Ital Nefrol ; 27(3): 282-9, 2010.
Artículo en Italiano | MEDLINE | ID: mdl-20540021

RESUMEN

The natural history of urolithiasis includes the risk of recurrence and of the development of chronic kidney and/or bone disease, which is why a thorough clinical and metabolic evaluation of these patients is of the utmost importance at disease onset. This paper is aimed at identifying the type of urolithiasis, the related risk factors, and the corresponding treatment options. The diagnostic and therapeutic approach described here includes 1) accurate history taking to detect secondary nephrolithiasis and screen for the main risk factors for kidney and bone disease; 2) metabolic evaluation graded according to different complexity levels based on the severity of the disease and the presence of risk factors; 3) carrying out appropriate imaging procedures. The resulting information allows to plan treatment based either on general rules of lifestyle and diet, or on selected medical intervention, if necessary. This report, which is based on current guidelines, was produced by the Gruppo Italiano di Studio Multidisciplinare per la Calcolosi Renale. It is addressed to all professionals involved in the management of patients suffering from nephrolithiasis, first of all general practitioners, who often become involved immediately at the onset of the disease.


Asunto(s)
Cálculos Urinarios/diagnóstico , Cálculos Urinarios/terapia , Humanos
5.
J Nephrol ; 22(1): 137-43, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19229829

RESUMEN

BACKGROUND: There is some evidence suggesting a close relationship between polyunsaturated fatty acids (PUFAs) and renal inflammation and fibrosis, which are crucial stages in chronic kidney disease. METHODS: To verify the role of PUFAs in renal fibrosis processes, we investigated the effects of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (AA) on the gene expression of TGFbeta, fibronectin (FN), connective tissue growth factor (CTGF) and type IV collagen (COLIV) in human mesangial cells, in the absence or presence of angiotensin II (AngII), using reverse transcriptase PCR. RESULTS: The addition of AA to mesangial cell cultures induced a significant up-regulation of TGFbeta, FN, CTGF and COLIV expression, similar to that induced by AngII, while EPA and DHA had no stimulatory effects. The coincubation of cells with AngII and AA potentiated AngII-induced gene expression; on the contrary, the coexposure of cells to EPA or DHA suppressed the AngII- and AA-induced up-regulation of TGFbeta, FN, CTGF and COLIV. CONCLUSION: We conclude that the PUFAs have different effects, dependent on their chemical structure, on the AngII-TGFbeta system, a major regulator of the renal fibrotic process. Our in vitro results may provide new therapeutic options toward interrupting the irreversible process of renal fibrosis and ameliorating chronic renal injury.


Asunto(s)
Angiotensina II/farmacología , Ácido Araquidónico/farmacología , Ácidos Docosahexaenoicos/farmacología , Ácido Eicosapentaenoico/farmacología , Fibronectinas/metabolismo , Células Mesangiales/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Células Cultivadas , Colágeno Tipo IV/metabolismo , Factor de Crecimiento del Tejido Conjuntivo/metabolismo , Fibrosis/metabolismo , Fibrosis/patología , Humanos , Riñón/metabolismo , Riñón/patología , Células Mesangiales/efectos de los fármacos , Células Mesangiales/patología , Regulación hacia Arriba/efectos de los fármacos
6.
Connect Tissue Res ; 48(1): 34-8, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17364665

RESUMEN

To investigate the possible role for unsaturated free fatty acids in osteoblast adhesion, the effects of two polyunsaturated fatty acids (PUFAs), arachidonic (AA) and eicosapentaenoic (EPA) acids, and of one monounsaturated fatty acid, oleic acid (OA), on adhesion to the substrate and on gene expression of three extracellular matrix macromolecules were investigated in an in vitro model system--cultured osteoblast-like human cells. AA, but neither EPA nor OA, diminished bone cell adhesion, whereas both EPA and OA, but not AA, increased gene expression of type I collagen and fibronectin via a transforming growth factor-beta-independent mechanism. These results extend previous evidence for unsaturated fatty acids in bone cell metabolism.


Asunto(s)
Ácido Araquidónico/farmacología , Adhesión Celular/efectos de los fármacos , Ácido Eicosapentaenoico/farmacología , Proteínas de la Matriz Extracelular/biosíntesis , Ácidos Grasos no Esterificados/farmacología , Expresión Génica/efectos de los fármacos , Osteoblastos/metabolismo , Línea Celular , Colágeno Tipo I/biosíntesis , Fibronectinas/biosíntesis , Humanos , Ácido Oléico/farmacología , Osteoblastos/efectos de los fármacos , Factor de Crecimiento Transformador beta/fisiología
7.
Artículo en Inglés | MEDLINE | ID: mdl-16870415

RESUMEN

The effect of arachidonic acid (AA) on intracellular Ca(2+) concentration ([Ca(2+)]i) in human osteoblasts MG63 was studied. AA caused a concentration-dependent increase in [Ca(2+)]i, mainly due to inward Ca(2+) transport from extracellular environment. Moreover, AA in Ca(2+) -free medium produced a small, transient increase of [Ca(2+)]i, indicating that AA may also trigger Ca(2+) release from intracellular stores. Because the [Ca(2+)]i response to AA was inhibited by the cyclooxygenase (COX) inhibitor indomethacin, we tested the effect of prostaglandins (PGs), products of COX pathway. PGs E1 and E2 caused an increase in [Ca(2+)]i, which, however, was far lower than that obtained with AA. The [Ca(2+)]i response to AA was not inhibited by nifedipine, suggesting that AA did not activate a voltage-dependent Ca(2+) channel. Our results indicate that AA could modulate [Ca(2+)]i in MG63 human osteoblasts, where it may influence Ca(2+) transport across both plasma and endoplasmic membranes. Furthermore, they suggest that osteoblast activity may be modulated by AA.


Asunto(s)
Ácido Araquidónico/farmacología , Calcio/metabolismo , Osteoblastos/efectos de los fármacos , Osteoblastos/metabolismo , Alprostadil/farmacología , Señalización del Calcio/efectos de los fármacos , Línea Celular , Dinoprostona/farmacología , Humanos
8.
Mol Membr Biol ; 22(5): 411-20, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16308275

RESUMEN

Haemolysis is usually episodic in glucose-6-phosphate dehydrogenase (G6PD) deficiency, often triggered by a period of oxidative stress. In the present work, we investigate a possible biochemical mechanism underlying the enhanced susceptibility of G6PD deficient red blood cells (RBC) to oxidative stress. We analysed eight male subjects with Mediterranean glucose-6P-dehydrogenase deficiency (G6PDd), class II, for their ability in phosphorylating erythrocyte membrane band 3 following oxidative and osmotic stress. Our findings show that this sensitivity is connected to an early membrane band 3 Tyr-phosphorylation in the presence of diamide. However, since both Syk, and Lyn kinases, and SHP-2 phosphatase, mostly implicated in the band 3 P-Tyr level regulation, are alike in content and activity in normal and patient erythrocytes, an alteration in the membrane organization is likely the cause of the anomalous response to the oxidant. We report, in fact, that hypertonic-induced morphological change in G6PDd erythrocyte induces a higher membrane band 3 Tyr-phosphorylation, suggesting a pre-existing membrane alteration, likely due to the chronic lowering of the redox systems in patients. We also report that 1-chloro-2,4-dinitrobenzene-pre-treatment of normal red cells can alter the normal protein-protein and protein-membrane interaction under hypertonic rather than oxidative stress, thus partially resembling the response in patients, and that RBC may utilize a wider range of redox defence, under oxidative conditions, including, but not exclusively, NADPH and glutathione. On the whole, these results would encourage a different approach to the evaluation of the effects of pharmacological administration to patients, giving more attention to the possible drug-induced membrane alteration evidenced by the abnormal band 3 Tyr-phosphorylation.


Asunto(s)
Proteína 1 de Intercambio de Anión de Eritrocito/metabolismo , Eritrocitos/enzimología , Deficiencia de Glucosafosfato Deshidrogenasa/enzimología , Tirosina/metabolismo , Androsterona/farmacología , Antioxidantes/metabolismo , Diamida/farmacología , Dinitroclorobenceno/farmacología , Eritrocitos/efectos de los fármacos , Glutatión/metabolismo , Humanos , Masculino , NADP/metabolismo , Presión Osmótica , Estrés Oxidativo , Fosforilación , Proteínas Tirosina Fosfatasas/metabolismo
9.
Transplantation ; 80(9): 1349-52, 2005 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-16314806

RESUMEN

To investigate the relationship between polyunsaturated fatty acid (PUFA) and bone metabolism in renal transplant patients, plasma phospholipid (PP) PUFA levels, biochemical markers of bone turnover and bone mineral density (BMD) were determined in 22 recipients of a first renal allograft at baseline and after a mean 24.4 month follow-up. A significant increase in PP n-3 PUFA content, in the [n-3 PUFA/ arachidonic acid] ratio and in BMD values was observed, as well as a close correlation between the increase in PP n-3 PUFA content and femoral neck BMD. Multivariate regression analysis showed that BMD improvement was positively related to PP n-3 PUFA variation and baseline PP eicosapentaenoic acid levels, and negatively to PP arachidonic acid modification. Tacrolimus- versus cyclosporine-treated patients demonstrated a significant increase in femoral neck BMD and PP n-3 PUFA content. This is the first longitudinal study showing a link between PP-PUFA composition and bone disease in renal transplantation.


Asunto(s)
Enfermedades Óseas/etiología , Ácidos Grasos Insaturados/sangre , Trasplante de Riñón/efectos adversos , Fosfolípidos/sangre , Adulto , Ácido Araquidónico/sangre , Biomarcadores/sangre , Densidad Ósea , Remodelación Ósea , Ciclosporina/uso terapéutico , Ácidos Grasos Omega-3/sangre , Femenino , Cuello Femoral/metabolismo , Humanos , Inmunosupresores/uso terapéutico , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Tacrolimus/uso terapéutico
10.
Urol Int ; 75(2): 97-101, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16123560

RESUMEN

Clinical and experimental investigations seem to underline the important role of fatty acids in the pathogenesis of hypercalciuria, a well-known risk factor for lithogenesis. To evaluate the relationships between the previously reported increase in plasma phospholipid arachidonic acid level and the factors responsible for calcium metabolism in idiopathic calcium nephrolithiasis, a best-fit model was constructed. This new statistical application shows a causal relationship between plasma phospholipid arachidonic acid content, intestinal calcium absorption, biochemical markers of bone turnover, urinary calcium excretion and bone mineral density at the lumbar spine. This model suggests that a defect in the phospholipid fatty acid composition could represent the primary event responsible for the mosaic of metabolic and clinical alterations that are distinctive features of renal stone formers, such as kidney, intestine, and bone calcium metabolism, and several forms of idiopathic hypercalciuria.


Asunto(s)
Trastornos del Metabolismo del Calcio/complicaciones , Ácidos Grasos/metabolismo , Cálculos Renales/etiología , Cálculos Renales/metabolismo , Animales , Calcio/orina , Trastornos del Metabolismo del Calcio/diagnóstico , Modelos Animales de Enfermedad , Humanos , Cálculos Renales/fisiopatología , Medición de Riesgo , Sensibilidad y Especificidad
11.
Clin Sci (Lond) ; 109(2): 177-82, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15801909

RESUMEN

A specific modulatory effect of PUFAs (polyunsaturated fatty acids) on gene expression of some cytokines involved in bone remodelling has been reported previously. In particular, although a direct action of AA (arachidonic acid) on bone cytokine gene expression has been shown in human osteoblastic cells, OA (oleic acid) and EPA (eicosapentaenoic acid) were ineffective. Since the NO (nitric oxide) system has also been shown to have an important modulatory activity on osteoblasts, osteoclasts and bone metabolism, in the present study we have investigated the effects of PUFAs on iNOS (inducible NO synthase) gene expression in a human osteoblast-like cell line. AA induced a significant increase in iNOS mRNA expression, whereas EPA and OA had no stimulatory effects but instead caused a significant inhibition of AA-induced iNOS gene expression. Blocking of the COX (cyclo-oxygenase) pathway did not inhibit AA-induced iNOS expression. AA action was inhibited instead by the addition of calphostin C and genistein, inhibitors of PKC (protein kinase C) and tyrosine kinases respectively. Experiments performed with specific anti-cytokine antibodies showed a significant decrease in iNOS expression in AA-treated osteoblastic cells, suggesting that both cytokine-dependent and -independent mechanisms account for the effects of AA on iNOS gene expression. In conclusion, our investigation clearly shows specific effects of PUFAs on iNOS expression in human osteoblast-like cells with a cytokine-dependent and -independent mechanism. These results might have clinical relevance and are of interest for understanding the reported beneficial effects of dietary PUFA manipulation on the prevention and/or treatment of primary and secondary bone disease.


Asunto(s)
Ácido Araquidónico/farmacología , Óxido Nítrico Sintasa/genética , Osteoblastos/enzimología , ARN Mensajero/análisis , Antiinflamatorios/farmacología , Anticuerpos Monoclonales/farmacología , Aspirina/farmacología , Línea Celular Tumoral , Inhibidores de la Ciclooxigenasa/farmacología , Citocinas/antagonistas & inhibidores , Ácido Eicosapentaenoico/farmacología , Activación Enzimática , Genisteína/farmacología , Humanos , Naftalenos/farmacología , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Ácido Oléico/farmacología , Osteoblastos/efectos de los fármacos , Proteína Quinasa C/antagonistas & inhibidores , Proteínas Tirosina Quinasas/antagonistas & inhibidores
12.
Eur J Endocrinol ; 150(6): 799-807, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15191350

RESUMEN

OBJECTIVE: Vascular endothelial growth factor (VEGF) exists in three main splice variants, characterized by 121, 165 and 189 amino acids (VEGF 121, VEGF 165 and VEGF 189) and acts via two specific receptors: VEGF-R1 or Flt-1 and VEGF-R2 or KDR. VEGF plays an important role in the pathogenesis of diabetic retinopathy. This study examined the relationship between VEGF and its isoforms and the severity of diabetic nephropathy in type 2 diabetes. DESIGN: We evaluated the glomerular gene expression of VEGF and its receptors and studied the relationships with renal functional and structural parameters in type 2 diabetic patients. METHODS: Glomeruli from 17 kidney biopsies were microdissected; 14 out of 17 biopsies were also subjected to electron microscopic morphometric analysis to estimate glomerular structural parameters. VEGF mRNA was studied by comparative kinetic RT-PCR and real-time RT-PCR in order to identify the three different isoforms and to quantify VEGF, VEGF-R1 and VEGF-R2 mRNA levels. RESULTS: (i) Glomerular VEGF mRNA levels were inversely related to albumin excretion rate (r=-0.66, P=0.004); (ii) both the degree of mesangial and mesangial matrix expansion were inversely related to VEGF 165 mRNA levels (r=-0.73, P=0.005 and r=-0.64, P=0.017), and directly to VEGF 121 mRNA levels (r=0.74, P=0.003 and r=0.73, P=0.004); and (iii) VEGF and VEGF-R2 mRNA levels were directly related (r=0.62, P=0.033). CONCLUSIONS: These findings suggested that quantitative and qualitative changes in VEGF expression are present in type 2 diabetic patients with nephropathy and might be involved in the pathogenesis and progression of diabetic glomerulopathy.


Asunto(s)
Diabetes Mellitus Tipo 2/metabolismo , Expresión Génica , Glomérulos Renales/química , Factor A de Crecimiento Endotelial Vascular/genética , Anciano , Albuminuria , Empalme Alternativo , Biopsia , Diabetes Mellitus Tipo 2/patología , Diabetes Mellitus Tipo 2/fisiopatología , Nefropatías Diabéticas/metabolismo , Nefropatías Diabéticas/patología , Nefropatías Diabéticas/fisiopatología , Femenino , Mesangio Glomerular/patología , Humanos , Glomérulos Renales/patología , Glomérulos Renales/fisiopatología , Masculino , Persona de Mediana Edad , ARN Mensajero/análisis , Receptores de Factores de Crecimiento Endotelial Vascular/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
14.
Biochemistry ; 42(15): 4485-91, 2003 Apr 22.
Artículo en Inglés | MEDLINE | ID: mdl-12693944

RESUMEN

There are several pieces of evidence supporting the important role that essential fatty acids (EFAs) and their metabolites play in regulating calcium and bone metabolism, and their relevance to the pathobiology of bone disease, with particular reference to modulating effects on cytokines. We found that arachidonic acid (AA) triggers a cell signal in osteoblasts and leads to the expression of IL-6. To explore the biochemical pathways involved in AA induction of cytokine gene expression, we evaluated the potential protein kinase C (PKC) dependent mechanism accounting for the AA effect on IL-6 gene expression. The osteoblast-like cell line MG-63 was pretreated with calphostin C, a PKC inhibitor, or phorbol 12-myristate 13-acetate (PMA) for an extended period, a condition which causes PKC downregulation, and subsequently with AA. After these treatments, IL-6 gene expression was no longer evident. We also showed that PKC and, in particular, PKC alpha, which are both recruited to the particulate fraction, undergo proteolysis and autophosphorylation; all of these steps are required for PKC activation and, subsequently, for AA-induced signaling. It is interesting that other unsaturated fatty acids, such as oleic acid (OA) or eicosapentaenoic acid (EPA), are unable to induce either PKC activation or IL-6 gene expression.


Asunto(s)
Ácido Araquidónico/metabolismo , Interleucina-6/genética , Proteína Quinasa C/metabolismo , Citocinas/biosíntesis , Citocinas/genética , Ácido Eicosapentaenoico , Activación Enzimática , Ácidos Grasos Insaturados/metabolismo , Humanos , Interleucina-6/biosíntesis , Ácido Oléico/metabolismo , Proteína Quinasa C-alfa
17.
J Nephrol ; 15(6): 601-4, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12495271

RESUMEN

Epidemiological, clinical and experimental evidence suggests that fatty acids may have an effect (due to their chemical structure) on calcium metabolism in animals and man. Fatty acid deficiency in animals can lead to a loss of bone calcium and matrix, resulting in marked bone demineralization, and treatment with a mixture of omega-3 and omega-6 polyunsaturated fatty acids can induce significant reduction in some biochemical markers of bone reabsorption. A relationship, between phospholipid fatty acid content, calcium-regulating hormones and intestinal, renal, and bone calcium metabolism alterations, has been reported in patients with renal stones and hypercalciuria. Recent studies have shown specific effects of fatty acids on the gene expression of some bone cytokines. Fatty acids might be involved in calcium metabolism influencing cellular calcium ion transport directly, as second messengers, or generating, through the cyclooxygenase pathway, potential biological mediators which have complex effects on bone remodeling. Experimental and clinical documentation of the specific and indirect effects of fatty acids on calcium and bone metabolism could open up new and interesting clinical prospects.


Asunto(s)
Huesos/metabolismo , Trastornos del Metabolismo del Calcio/etiología , Calcio/metabolismo , Ácidos Grasos/metabolismo , Animales , Densidad Ósea , Remodelación Ósea/fisiología , Trastornos del Metabolismo del Calcio/fisiopatología , Ácidos Grasos Esenciales/administración & dosificación , Ácidos Grasos Insaturados/administración & dosificación , Humanos , Medición de Riesgo , Sensibilidad y Especificidad
18.
J Am Soc Nephrol ; 13(11): 2730-6, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12397043

RESUMEN

Prospective studies have established smoking as an independent risk factor for diabetic nephropathy, suggesting an adverse effect of smoking on glomerular structure and function. To test this hypothesis, this study evaluated GFR, metabolic profile, and smoking habits in 96 patients with type 2 diabetes and abnormal albumin excretion rate (AER). All patients underwent percutaneous kidney biopsy: mesangial fractional volume [Vv (mes/glom)] and glomerular basement membrane (GBM) width were estimated by electron microscopic morphometric analysis; interstitial fibrosis was estimated semiquantitatively by light microscopy. Forty-eight patients were smokers. Compared with nonsmokers, smokers had higher values of HbA(1c) (P = 0.002), AER (P = 0.026), GFR (P = 0.004), and GBM width (P = 0.002); moreover, GFR was higher in current smokers than in former smokers (P = 0.001), and GBM width was related to heavy smoking (F = 5.4; P = 0.006). Multiple linear regression analyses revealed that HbA(1c) was associated with fasting blood glucose (beta coef = 0.52; P < 0.001), smoking habit (beta coef = 0.31; P < 0.001), insulin therapy (beta coef = 0.22; P = 0.012), and male gender (beta coef = -0.20; P = 0.020); AER was related to Vv (mes/glom) (beta coef = 0.32; P = 0.003), GBM width (beta coef = 0.28; P = 0.016), and interaction between smoking habit and HbA(1c) (beta coef = 0.24; P = 0.040). GFR was negatively correlated with Vv (mes/glom) (beta coef = -0.57; P < 0.001) and age (beta coef = -0.29; P = 0.001) and positively correlated with GBM width (beta coef = 0.27; P = 0.012), heavy current smoking (beta coef = 0.24; P = 0.028), and HbA(1c) (beta coef = 0.28; P = 0.040); GBM width was explained by Vv (mes/glom) (beta coef = 0.53; P < 0.001), interaction between heavy smoking and HbA(1c) levels (beta coef = 0.25; P = 0.003), and diabetes duration (beta coef = 0.23; P = 0.010). Smoking habit did not affect the index of interstitial fibrosis. In conclusion, cigarette smoking affects glomerular structure and function in type 2 diabetes and may be an important factor for the onset and progression of diabetic nephropathy.


Asunto(s)
Diabetes Mellitus Tipo 2/patología , Diabetes Mellitus Tipo 2/fisiopatología , Glomérulos Renales/patología , Glomérulos Renales/fisiopatología , Fumar/efectos adversos , Albuminuria/orina , Membrana Basal/patología , Estudios Transversales , Femenino , Tasa de Filtración Glomerular , Hemoglobina Glucada/análisis , Humanos , Masculino , Microscopía Electrónica , Persona de Mediana Edad
19.
Nephron ; 91(3): 486-91, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12119482

RESUMEN

BACKGROUND: An anomalous plasma phospholipid polyunsaturated fatty acid composition has been reported in calcium nephrolithiasis, and was proposed to play a crucial role in the pathogenesis of hypercalciuria and hyperoxaluria, well-known risk factors for lithogenesis. METHODS: To confirm this hypothesis, we administered rats three different diets rich in coconut, soybean and fish oils, and evaluated their effect on plasma urinary calcium and oxalate excretion, since the quality of fatty acids represents an important factor able to influence the activity of delta-6-desaturase, the rate-limiting enzyme in the biosynthetic pathway of highly unsaturated fatty acids. RESULTS: In comparison with coconut and fish oil, dietary supplementation with soybean oil increased plasma phospholipid arachidonic acid and serum 1,25-vitamin D(3) values, as well as renal tissue calcium content and urinary excretion of sodium, oxalate and calcium. CONCLUSIONS: Our findings demonstrate that the quality of fatty acids may modify the urine excretion of calcium and oxalate, confirming our previous hypothesis of a pathogenetic link between cellular membrane phospholipid polyunsaturated fatty acid composition and calcium nephrolithiasis. In addition, our study provides new insights into the relationship between dietary, environmental factors and renal stone disease.


Asunto(s)
Calcio/orina , Grasas de la Dieta/administración & dosificación , Suplementos Dietéticos , Ácidos Grasos/administración & dosificación , Ácido Oxálico/orina , Animales , Ácidos Araquidónicos/sangre , Colecalciferol/sangre , Masculino , Ratas , Ratas Sprague-Dawley , Sodio/orina
20.
Blood ; 100(1): 276-82, 2002 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-12070037

RESUMEN

Tyr phosphorylation of the multifunctional transmembrane protein band 3 has been implicated in several erythrocyte functions and disorders. We previously demonstrated that pervanadate treatment of human erythrocytes induces band-3 Tyr phosphorylation, which is catalyzed by the sequential action of tyrosine kinase Syk and tyrosine kinase(s) belonging to the Src family. In this study, we show that Tyr phosphorylation of band 3, elicited by pervanadate, N-ethylmaleimide, or diamide, greatly increases band-3 interaction with the tyrosine phosphatase SHP-2 in parallel with the translocation of SHP-2 to erythrocyte membranes. These events seem to be mediated by Src-like catalyzed phosphorylation of band 3 because both SHP-2 translocation to cellular membranes and its interaction with Tyr-phosphorylated protein are greatly counteracted by PP2, a specific inhibitor of Src kinases. Binding-competition experiments demonstrate that SHP-2 recruitment to band 3 occurs via its SH2 domain(s). In particular, our data support the view that SHP-2 docks specifically with P-Y359 of band 3. Experiments performed with intact erythrocytes in the presence of the SHP-2 inhibitor calpeptin suggest that, once recruited to Tyr-phosphorylated band 3, the tyrosine phosphatase dephosphorylates the protein. P-Y8, 21, and 904 are the residues affected by SHP-2, as judged by (32)P-peptide mapping of band 3 digested with trypsin. These results indicate that in treated erythrocytes, recruitment of cytosolic SHP-2 to band 3 is a prerequisite for the subsequent dephosphorylation of the transmembrane protein.


Asunto(s)
Proteína 1 de Intercambio de Anión de Eritrocito/metabolismo , Eritrocitos/metabolismo , Proteínas Tirosina Fosfatasas/metabolismo , Sitios de Unión , Membrana Celular/química , Membrana Celular/metabolismo , Citosol/química , Citosol/metabolismo , Inhibidores Enzimáticos/farmacología , Eritrocitos/química , Eritrocitos/enzimología , Humanos , Péptidos y Proteínas de Señalización Intracelular , Fosforilación/efectos de los fármacos , Unión Proteica , Transporte de Proteínas , Proteína Tirosina Fosfatasa no Receptora Tipo 11 , Proteínas Tirosina Fosfatasas/antagonistas & inhibidores , Proteínas Tirosina Fosfatasas con Dominio SH2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA